FOLH1 and neoplasm: To increase the tumor-to-kidney absorbed dose or biologically effective dose (BED) ratio, amino acids are administered to block unspecific uptake at some institutions analogous to peptide receptor radionuclide therapy (PRRT), however evidence on the relevance of this approach for PSMA-targeted radionuclide therapy is still missing.